THE Society of Hospital Pharmacists of Australia (SHPA) this morning unveiled a new $30,000 research grant which it says will provide “an unprecedented opportunity for Australian clinical pharmacists to improve patient safety in the use of high-risk medicines”.
The ‘Emerging Researcher Grant’ will be formally announced by SHPA in partnership with Australasian hospital and specialty post-patent pharmaceutical firm Juno, and almost doubles the pool of funding available via the Society’s National Translational Research Collaborative (NTRC).
SHPA ceo Kristin Michaels said the grant was perfect for emerging pharmacy researchers with previous proven experience, providing a ‘next step’ towards larger future research projects while at the same time funding initiatives that directly improve patient safety in current practice.
The NTRC is a virtual hub connecting clinical pharmacy researchers to build capacity and inter-hospital partnerships.
It is now welcoming applications for the new funding until 5pm AEST on Sun 29 Jul, inviting researchers to submit a literature review and research gap identification.
“NTRC helps turn more pharmacists into pharmacy researchers, an advancement that furthers the workforce as a whole, ensuring the development and introduction of new and improved clinical services,” Michaels said.
A full timeline along with application criteria and other information is now available at shpa.org.au/ntrc.